169 related articles for article (PubMed ID: 33855736)
21. Lacosamide dosing in patients receiving continuous renal replacement therapy.
Chaijamorn W; Phunpon S; Sathienluckana T; Charoensareerat T; Pattharachayakul S; Rungkitwattanakul D; Srisawat N
J Intensive Care; 2023 Nov; 11(1):50. PubMed ID: 37946296
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of Imipenem/Cilastatin Burn Intensive Care Unit Patients Undergoing High-Dose Continuous Venovenous Hemofiltration.
Boucher BA; Hudson JQ; Hill DM; Swanson JM; Wood GC; Laizure SC; Arnold-Ross A; Hu ZY; Hickerson WL
Pharmacotherapy; 2016 Dec; 36(12):1229-1237. PubMed ID: 27862103
[TBL] [Abstract][Full Text] [Related]
24. In vivo Elimination of Clonidine by Continuous Venovenous Hemofiltration in Critically Ill Patients.
van den Oever HLA; Zeeman M; Nassikovker P; Bles C; van Steveninck FAL; de Meijer AR; Kruisdijk-Gerritsen A; Arbouw M
Blood Purif; 2020; 49(5):622-626. PubMed ID: 31962323
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
27. Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.
Charoensareerat T; Chaijamorn W; Kerdnimith P; Kosumwisaisakul N; Teeranaew P; Rungkitwattanakul D; Boonpeng A; Srisawat N; Pattharachayakul S
Blood Purif; 2023; 52(6):503-515. PubMed ID: 37231811
[TBL] [Abstract][Full Text] [Related]
28. Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration.
Möhlmann JE; van Luin M; Uijtendaal EV; Zahr N; Sikma MA
Br J Clin Pharmacol; 2023 Dec; 89(12):3753-3757. PubMed ID: 37675616
[TBL] [Abstract][Full Text] [Related]
29. Levetiracetam dosing in patients receiving continuous renal replacement therapy.
Chaijamorn W; Charoensareerat T; Rungkitwattanakul D; Phunpon S; Sathienluckana T; Srisawat N; Pattharachayakul S
Epilepsia; 2021 Sep; 62(9):2151-2158. PubMed ID: 34247386
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
[TBL] [Abstract][Full Text] [Related]
31. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
Kiser TH; Fish DN; Aquilante CL; Rower JE; Wempe MF; MacLaren R; Teitelbaum I
Crit Care; 2015 Feb; 19(1):32. PubMed ID: 25645660
[TBL] [Abstract][Full Text] [Related]
33. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
[TBL] [Abstract][Full Text] [Related]
34. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
[TBL] [Abstract][Full Text] [Related]
35. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
[TBL] [Abstract][Full Text] [Related]
36. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
Chappell K; Kimmons LA; Haller JT; Canada RB; He H; Hudson JQ
J Crit Care; 2021 Feb; 61():216-220. PubMed ID: 33217623
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
[TBL] [Abstract][Full Text] [Related]
39. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
[TBL] [Abstract][Full Text] [Related]
40. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
Garbez N; Mbatchi LC; Maseda E; Luque S; Grau S; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
Ther Drug Monit; 2021 Dec; 43(6):747-755. PubMed ID: 33560097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
